Literature DB >> 3972395

Primary acquired melanosis of the conjunctiva.

R Folberg, I W McLean, L E Zimmerman.   

Abstract

Forty-one cases of conjunctival primary acquired melanosis (PAM) were studied to determine the frequency of progression to malignant melanoma and to establish prognostic parameters for progression to melanoma. Two subdivisions were identified: lesions with cytologically atypical melanocytes (PAM with atypia, 28 lesions, 68.3 per cent) and those lacking cytologically atypical melanocytes (PAM without atypia, 13 lesions, 31.7 per cent). None of the lesions of PAM without atypia progressed to melanoma. Thirteen of the 28 lesions of PAM with atypia (46.4 per cent) progressed to melanoma. Progression to melanoma was more frequent in the lesions of PAM with atypia if basilar hyperplasia was not the dominant histologic pattern (90 per cent progression, P = 0.02) or if any epithelioid cells were present (75 per cent progression, P = 0.02). It was not possible to determine which lesions were atypical on the basis of clinical appearance. Lesions at risk for the development of melanoma should be totally extirpated.

Entities:  

Mesh:

Year:  1985        PMID: 3972395     DOI: 10.1016/s0046-8177(85)80061-7

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  25 in total

1.  Impression cytology of conjunctival melanosis and melanoma.

Authors:  A D Paridaens; A C McCartney; O M Curling; C J Lyons; J L Hungerford
Journal:  Br J Ophthalmol       Date:  1992-04       Impact factor: 4.638

2.  Multifocal amelanotic conjunctival melanoma and acquired melanosis sine pigmento.

Authors:  A D Paridaens; A C McCartney; J L Hungerford
Journal:  Br J Ophthalmol       Date:  1992-03       Impact factor: 4.638

3.  Primary Acquired Melanosis: Clinical, Histopathologic and Optical Coherence Tomographic Correlation.

Authors:  Yahya A Alzahrani; Smita Kumar; Hassan Abdul Aziz; Thomas Plesec; Arun D Singh
Journal:  Ocul Oncol Pathol       Date:  2015-11-12

4.  Cell growth and p53 expression in primary acquired melanosis and conjunctival melanoma.

Authors:  S Seregard
Journal:  J Clin Pathol       Date:  1996-04       Impact factor: 3.411

5.  Ophthalmic pterygium: a stem cell disorder with premalignant features.

Authors:  Jeanie Chui; Minas T Coroneo; Lien T Tat; Roger Crouch; Denis Wakefield; Nick Di Girolamo
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

6.  Amelanotic malignant melanoma of the conjunctiva in a young adult.

Authors:  Takashi Nabeshima; Katsura Kimura; Daijiro Kurosaka
Journal:  Jpn J Ophthalmol       Date:  2008-11-11       Impact factor: 2.447

7.  Primary acquired melanosis of the conjunctiva: experience with 311 eyes.

Authors:  Jerry A Shields; Carol L Shields; Arman Mashayekhi; Brian P Marr; Raquel Benavides; Archana Thangappan; Laura Phan; Ralph C Eagle
Journal:  Trans Am Ophthalmol Soc       Date:  2007

8.  Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia.

Authors:  P T Finger; G Czechonska; S Liarikos
Journal:  Br J Ophthalmol       Date:  1998-05       Impact factor: 4.638

Review 9.  Conjunctival melanoma and melanocytic intra-epithelial neoplasia.

Authors:  N Kenawy; S L Lake; S E Coupland; B E Damato
Journal:  Eye (Lond)       Date:  2012-12-07       Impact factor: 3.775

10.  Topical treatment options for conjunctival neoplasms.

Authors:  Jonathan W Kim; David H Abramson
Journal:  Clin Ophthalmol       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.